How should I assess and manage a child with a two‑month history of chronic cough that is dry by day and wet at night, wheezing, nasal congestion, partial relief with albuterol (salbutamol) inhaler, no fever or dyspnea, and bilateral cerumen impaction?

Assessment and Management of Chronic Cough with Wheezing in a Child

Primary Recommendation

This child has reached the 2-month (8-week) threshold for chronic cough and requires immediate initiation of a 2-week course of antibiotics targeting protracted bacterial bronchitis (PBB), not continuation of inhaled corticosteroids alone. 1, 2

---

Critical Diagnostic Clarification

Cough Phenotype Assessment

• The nighttime "wet and phlegmy" cough is the defining characteristic that mandates antibiotic therapy, not asthma treatment. 1, 2
• The daytime dry cough combined with nighttime wet cough still qualifies as chronic wet cough requiring antibiotics. 1, 3
• In young children, "wet" cough describes a loose, rattling, self-propagating sound from airway secretions—visible sputum is not required for diagnosis. 4

Wheezing Does Not Equal Asthma

• Wheezing in the context of chronic wet cough most likely represents airway secretions and bacterial infection, not asthma. 1
• The CHEST guidelines explicitly state that cough sensitivity and specificity for wheeze is poor, and chronic cough is not associated with airway inflammation profiles suggestive of asthma. 4
• Do not diagnose asthma based on cough and wheezing alone without additional asthma-specific features (recurrent wheeze episodes, exercise-induced symptoms, nocturnal awakenings beyond cough, family history of atopy). 1, 4

---

Immediate Management Plan

First-Line Antibiotic Therapy

• Prescribe amoxicillin-clavulanate for 2 weeks as first-line treatment targeting Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. 1, 2, 5
• Dosing: 45 mg/kg/day divided every 12 hours for children under 5 years. 5
• This is a Grade 1A recommendation from CHEST guidelines—the highest level of evidence. 1

Role of Inhaled Corticosteroids

• The current plan to restart inhaled corticosteroids (orange puffer) is appropriate ONLY as a short 2-4 week trial IF the child has risk factors for asthma AND only after confirming the wet cough phenotype. 1
• The recommended dose is 400 mcg/day beclomethasone equivalent (not higher doses). 1
• However, antibiotics should be the PRIMARY treatment given the 2-month duration of wet cough. 1, 2
• If inhaled corticosteroids are used concurrently, the child MUST be reassessed at 2-4 weeks, and ICS should be stopped if no improvement occurs—do not increase the dose. 1

Bronchodilator Use

• Continue salbutamol (blue puffer) as needed for symptomatic relief of wheezing. 6
• Salbutamol provides bronchodilation but does not treat the underlying bacterial infection causing the wet cough. 6

---

Structured Follow-Up Algorithm

Time Point	Assessment	Action
Week 2	Cough resolved after antibiotics	Diagnose protracted bacterial bronchitis (PBB); stop antibiotics. [1,2]
Week 2	Wet cough persists	Extend antibiotics for an additional 2 weeks (total 4 weeks). [1,2]
Week 4	Wet cough still present after 4 weeks total antibiotics	Refer for flexible bronchoscopy with quantitative cultures and consider chest CT. [1,2,7]
Any time	Specific cough pointers emerge (digital clubbing, coughing with feeding, failure to thrive, hemoptysis)	Stop empirical treatment; proceed directly to investigations (bronchoscopy, CT, aspiration evaluation, immunology workup). [1,2]

---

Re-Evaluation of Inhaled Corticosteroid Trial

When ICS Are Appropriate

• ICS may be warranted IF risk factors for asthma are present (family history of atopy, personal history of eczema, recurrent wheeze episodes beyond this illness). 1
• The trial should be limited to 2-4 weeks, and the child MUST be re-evaluated. 1
• If cough resolves with ICS, do not automatically diagnose asthma—resolution may be due to spontaneous resolution (period effect) or transient ICS-responsive inflammation. 1

When ICS Are NOT Appropriate

• Do not use ICS as first-line treatment for chronic wet cough—antibiotics are the evidence-based intervention. 1, 2, 7
• Cough unresponsive to ICS should NOT be treated with increased ICS doses. 1
• In children with wheeze without asthma, oral steroids conferred no benefit and were associated with increased hospitalizations. 1

---

Management of Bilateral Cerumen Impaction

Ear-Cough Reflex Consideration

• The ears should always be examined in patients with chronic cough because the Arnold's ear-cough reflex can be elicited by foreign material or structures (e.g., hair) resting on the eardrum. 1
• However, this is a very rare cause of childhood chronic cough. 1
• The current plan for mineral oil drops monthly is appropriate for cerumen management. 1

---

Critical Pitfalls to Avoid

Antibiotic Timing

• Do not wait until 4 weeks to initiate antibiotics in a child with persistent wet cough without specific cough pointers—the 2-week mark is appropriate for treatment initiation in the context of chronic wet cough lasting 2 months. 2, 4
• The child has already exceeded the 4-week chronic cough threshold (at 8 weeks), making antibiotic therapy immediately indicated. 1, 2

Asthma Overdiagnosis

• Do not assume all coughs with wheezing are asthma—wet cough specifically suggests bacterial involvement requiring antibiotics. 2, 4, 8
• Most children with isolated chronic cough do not have asthma. 4
• The previous limited use of the orange puffer (ICS) without resolution supports that asthma is not the primary diagnosis. 1

Nasal Congestion

• Persistent nasal congestion for 2 months may represent upper airway cough syndrome (UACS), but this does not change the need for antibiotics given the wet cough phenotype. 8
• Nasal saline irrigation may be beneficial for UACS, but efficacy data are limited. 8
• Do not use topical decongestants in young children due to narrow therapeutic margins and risk of cardiovascular/CNS side effects. 4

Monitoring for Complications

• If the child develops specific cough pointers (digital clubbing, coughing with feeding, failure to thrive, hemoptysis), stop empirical treatment and proceed directly to investigations. 1, 2
• Persistent wet cough after 4 weeks of appropriate antibiotics warrants referral for bronchoscopy and chest CT to evaluate for underlying disease (e.g., bronchiectasis, immunodeficiency, aspiration). 1, 2, 7

---

Supportive Care Measures

Humidifier and Hydration

• Continue humidifier use at night for symptomatic relief. 4
• Ensure adequate hydration to thin respiratory secretions. 4

Oral Hygiene and Candidiasis Prevention

• Continue mouth rinsing after inhaled steroid use to prevent oral candidiasis. 1
• Monitor for white patches or oral soreness. 4

Environmental Modifications

• Eliminate exposure to environmental tobacco smoke (two cats, two dogs at home are less likely culprits than secondhand smoke). 4
• Pets are unlikely to be the primary cause given the wet cough phenotype and 2-month duration. 8

---

Summary of Evidence-Based Approach

The current plan overemphasizes asthma treatment (ICS) and underemphasizes the primary diagnosis of protracted bacterial bronchitis. 1, 2, 7 At 2 months of chronic wet cough, antibiotics are the first-line, Grade 1A recommendation, with ICS reserved for cases with clear asthma risk factors and only as an adjunct. 1, 2 The child should be reassessed at 2 weeks, with extension of antibiotics if wet cough persists, and referral for investigations if no improvement after 4 weeks total of antibiotic therapy. 1, 2, 7